Genome-Wide Polygenic Risk Score for Retinopathy of Type 2 Diabetes.

Abstract

Diabetic retinopathy (DR) is a common consequence in type 2 diabetes (T2D) and a leading cause of blindness in working-age adults. Yet, its genetic predisposition is largely unknown. Here, we examined the polygenic architecture underlying DR by deriving and assessing a genome-wide polygenic risk score (PRS) for DR. We evaluated the PRS in 6079 individuals with T2D of European, Hispanic, African, and other ancestries from a large-scale multi-ethnic biobank. Main outcomes were PRS association with DR diagnosis, symptoms and complications, and time to diagnosis, and transferability to non-European ancestries. We observed that PRS was significantly associated with DR. A standard deviation increase in PRS was accompanied by an adjusted odds ratio (OR) of 1.12 (95% CI 1.04-1.20; P\u2009=\u20090.001) for DR diagnosis. When stratified by ancestry, PRS was associated with the highest OR in European ancestry (OR\u2009=\u20091.22, 95% CI 1.02-1.41; P\u2009=\u20090.049), followed by African (OR\u2009=\u20091.15, 95% CI 1.03-1.28; P\u2009=\u20090.028) and Hispanic ancestries (OR\u2009=\u20091.10, 95% CI 1.00-1.10; P\u2009=\u20090.050). Individuals in the top PRS decile had a 1.8-fold elevated risk for DR versus the bottom decile (P\u2009=\u20090.002). Among individuals without DR diagnosis, the top PRS decile had more DR symptoms than the bottom decile (P\u2009=\u20090.008). The PRS was associated with retinal hemorrhage (OR\u2009=\u20091.44, 95% CI 1.03-2.02; P\u2009=\u20090.03) and earlier DR presentation (10% probability of DR by 4\xa0years in the top PRS decile versus 8\xa0years in the bottom decile). These results establish the significant polygenic underpinnings of DR and indicate the need for more diverse ancestries in biobanks to develop multi-ancestral PRS.